REFRACTORY CYTOPENIA OF CHILDHOOD: CLINICAL FEATURES, PATHOLOGIC FINDINGS AND EXPERIENCE OF BRAZILIAN COOPERATIVE GROUP OF PEDIATRIC MYELODYSPLASTIC SYNDROME

REFRACTORY CYTOPENIA OF CHILDHOOD: CLINICAL FEATURES, PATHOLOGIC FINDINGS AND EXPERIENCE OF BRAZILIAN COOPERATIVE GROUP OF PEDIATRIC MYELODYSPLASTIC SYNDROME

Bibliographic Details
Main Authors:	Caroline Ramalho Rosa, Rafael Balceiro, Aline Tansini, Thaís Regina Toledo De Santis, Gláucia Regina Costa Murra, Eduardo Caetano, Luiz Fernando Lopes, Anita Frisanco Oliveira
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	EJC Paediatric Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772610X2300079X

Similar Items

CLINICAL AND HEMATOLOGICAL PROFILE OF CHILDREN WITH CYTOPENIAS REFERRED TO THE BRAZILIAN COOPERATIVE GROUP OF PEDIATRIC MYELODYSPLASTIC SYNDROME
by: Caroline Ramalho Rosa, et al.
Published: (2023-12-01)

TELOMERE LENGHT AND CYTOPENIAS: ANALYSIS OF CHILDREN REFERRED TO BRAZILIAN COOPERATIVE GROUP OF CHILDHOOD MYELODYSPLASTIC SYNDROME
by: Rafael Balceiro, et al.
Published: (2023-12-01)

Refractory cytopenia of the childhood
by: M Chowdhry, et al.
Published: (2012-01-01)

CASE REPORT: AN UNUSUAL CASE OF REFRACTORY CYTOPENIA OF CHILDHOOD IN A PATIENT WITH DOWN SYNDROME?
by: Viviany Viana, et al.
Published: (2023-12-01)

Somatic genomic variants in refractory cytopenia of childhood
by: Diego F. Coutinho, et al.
Published: (2021-09-01)

Membranous glomerulonephritis in a patient with myelodysplastic syndrome-refractory cytopenia with multilineage dysplasia
by: Kwang Il Ko, et al.
Published: (2013-09-01)

PREVALENCE OF EXPOSURE TO SOCIO-ENVIRONMENTAL FACTORS IN MYELODYSPLASTIC SYNDROMES - A STUDY OF THE BRAZILIAN PEDIATRIC MYELODYSPLASTIC SYNDROME GROUP (GCB-SMD-PED)
by: Glaucia Regina Costa Murra, et al.
Published: (2023-12-01)

Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood
by: Anna M. Aalbers, et al.
Published: (2015-03-01)

24 Refractory lupus cytopenias
by: Eloisa Bonfa
Published: (2020-09-01)

Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood
by: Ayami Yoshimi, et al.
Published: (2014-04-01)

Refractory Autoimmune Cytopenias Treated With Venetoclax
by: Max J. Gordon, et al.
Published: (2019-06-01)

BIOLOGY OF BONE MARROW DISORDER CHARACTERIZE DISTINCT SUBTYPES OF REFRACTORY CYTOPENIA OF CHILDHOOD (RCC)
by: Martina Sukova, et al.
Published: (2023-12-01)

Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes
by: Márk Plander, et al.
Published: (2024-07-01)

LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome
by: Katja Kaastrup, et al.
Published: (2023-05-01)

Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
by: Rong He, et al.
Published: (2022-01-01)

Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia
by: Etienne Crickx, et al.
Published: (2021-08-01)

Alteration in endoglin-related angiogenesis in refractory cytopenia with multilineage dysplasia.
by: Mónica del Rey, et al.
Published: (2013-01-01)

Plasma proteome changes associated with refractory cytopenia with multilineage dysplasia
by: Čermák Jaroslav, et al.
Published: (2011-10-01)

Myelodysplastic syndrome versus idiopathic cytopenia of undetermined significance: the role of morphology in distinguishing between these entities
by: Talyta Ellen de Jesus dos Santos, et al.
Published: (2013-01-01)

Children with chronic-refractory autoimmune cytopenias: a single center experience
by: Tuba Hilkay Karapınar, et al.
Published: (2020-08-01)

Treatment for acquired aplasia and refractory cytopenia. Review of a historical cohort
by: Jesús González de Pablo, et al.
Published: (2022-10-01)

Inflammatory Cytokine Profiles Do Not Differ Between Patients With Idiopathic Cytopenias of Undetermined Significance and Myelodysplastic Syndromes
by: Amalie Bach Nielsen, et al.
Published: (2022-05-01)

Missing cells: pathophysiology, diagnosis and management of (pan)cytopenia in childhood
by: Miriam eErlacher, et al.
Published: (2015-07-01)

Cytopenia after chimeric antigen receptor T cell immunotherapy in relapsed or refractory lymphoma
by: Jin Zhou, et al.
Published: (2022-09-01)

Rescue treatment with eltrombopag in refractory cytopenias after allogeneic stem cell transplantation
by: Semra Aydin, et al.
Published: (2020-10-01)

ACCELERATED CLEARANCE OF ANTI-THYMOCYTE GLOBULIN IN CHILDREN TRANSPLANTED FOR REFRACTORY CYTOPENIA OF CHILDHOOD VERSUS APLASTIC ANEMIA IS ASSOCIATED WITH INCREASED RISK OF GVHD
by: Eva Koopman-Coenen, et al.
Published: (2023-12-01)

Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine
by: Asahito Hama, et al.
Published: (2015-11-01)

Cytopenia and T cell proliferation.
by: Beverley, P, et al.
Published: (1982)

Valproate-Induced Cytopenias
by: J Gordon Millichap
Published: (1990-10-01)

Dimorphic anemia and cytopenias
by: Prita Pradhan
Published: (2019-01-01)

JUVENILE MYELOMONOCYTIC LEUKEMIA WITH TELOMERE SHORTENING: CASE REPORT
by: Anita Frisanco Oliveira, et al.
Published: (2023-12-01)

Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia
by: Ayami Yoshimi, et al.
Published: (2007-03-01)

P790: THE EXPRESSION LEVEL OF WT1 MRNA IN PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE (ICUS) PROGRESSING TO MYELODYSPLASTIC SYNDROME (MDS)
by: X. Ye, et al.
Published: (2022-06-01)

STRUCTURE OF CYTOPENIA IN HIV PATIENTS
by: D. V. Baryshnikova, et al.
Published: (2019-05-01)

Rituximab for the treatment of autoimmune cytopenias
by: Sigbjørn Berentsen
Published: (2007-12-01)

Cytopenia associated with copper deficiency
by: Kaori Uchino, et al.
Published: (2021-11-01)

Unique ethnic features of <I>DDX41</I> mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia
by: Eun-Ji Choi, et al.
Published: (2021-02-01)

Mutations of the Shwachman-Bodian-Diamond syndrome gene in patients presenting with refractory cytopenia – do we have to screen?
by: Axel Karow, et al.
Published: (2010-04-01)

A rare case of myelodysplastic syndrome with refractory thrombocytopenia
by: Waqas Jehangir, et al.
Published: (2015-09-01)

Autoimmune Cytopenias in Chronic Lymphocytic Leukemia
by: Giovanni D'Arena, et al.
Published: (2013-01-01)